NPR3

Atrial natriuretic peptide receptor 3 · P17342 · NPR3 on Sugi Atlas →

1,695 patent compounds predicted against NPR3, 573 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL17424044 SCHEMBL17424044 0.78 6/20
SCHEMBL6530463 SCHEMBL6530463 0.55 6/20
SCHEMBL6530469 SCHEMBL6530469 0.55 6/20
SCHEMBL12215074 SCHEMBL12215074 0.58 5/20
SCHEMBL5634567 SCHEMBL5634567 0.50 5/20
SCHEMBL5634570 SCHEMBL5634570 0.50 5/20
SCHEMBL6529224 SCHEMBL6529224 0.56 4/20
SCHEMBL5906846 SCHEMBL5906846 0.55 4/20
SCHEMBL3122959 SCHEMBL3122959 0.53 4/20
SCHEMBL11290439 SCHEMBL11290439 0.49 4/20
SCHEMBL13021673 SCHEMBL13021673 0.34 4/20
SCHEMBL30437754 SCHEMBL30437754 0.55 3/20
SCHEMBL5906830 SCHEMBL5906830 0.52 3/20
SCHEMBL5906925 SCHEMBL5906925 0.51 3/20
SCHEMBL5906929 SCHEMBL5906929 0.51 3/20
SCHEMBL17203151 SCHEMBL17203151 0.47 3/20
SCHEMBL17203152 SCHEMBL17203152 0.47 3/20
SCHEMBL10210577 SCHEMBL10210577 0.45 3/20
SCHEMBL12627973 SCHEMBL12627973 0.45 3/20
SCHEMBL15524534 SCHEMBL15524534 0.42 3/20

Clinical trials — most relevant to NPR3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study Of The Usage Of Statins In A Community Heart Failure Population PHASE4COMPLETED
Effect of Renal deNervation on Arterial Stiffness and Haemodynamics in Patients With UncontRolled hypErtension (ENSURE) PHASE4UNKNOWN
Dose-comparison Study of Prednisone in Heart Failure PHASE3COMPLETED
A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure. PHASE3COMPLETED
The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI PHASE3COMPLETED
The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man PHASE2COMPLETED
Race, Natriuretic Peptides and Physiological Perturbations PHASE2COMPLETED
Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction PHASE1WITHDRAWN
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects PHASE1COMPLETED
Effects of Different Forms of a Natural Heart Hormone on Blood Pressure and Fluid Balance in Healthy Volunteers EARLY_PHASE1COMPLETED
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome nanCOMPLETED
Ankle Brachial Index Versus Conventional Cardiac Risk Indices nanUNKNOWN
C-Type Natriuretic Peptide and Achondroplasia nanCOMPLETED
Diagnostic and Prognostic Role of Troponin and Brain Natriuretic Peptide in Pediatric Patients With Cardiomyopathy in Correlation to Echocardiography Findings nanUNKNOWN
Pharmacogenomics in Pulmonary Arterial Hypertension nanWITHDRAWN
A Biomarker to Detect Salt Sensitivity nanCOMPLETED
Analysis of Cardiac Biomarker Racial Discrepancies nanENROLLING_BY_INVITATION
Qatar Cardiovascular Biorepository of AF Patients nanUNKNOWN
Neurological Prognostication of Patients in Therapeutic Hypothermia After Cardiac Arrest nanCOMPLETED
B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading nanCOMPLETED
The Natriuretic Peptide System in African-Americans. nanCOMPLETED
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study nanRECRUITING
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide (Chemiluminescence Method) nanCOMPLETED
Heart Failure in the Community nanCOMPLETED
ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study nanCOMPLETED
Effects of Nesiritide in Pediatric Patients With Heart Failure nanWITHDRAWN
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure nanUNKNOWN
The Influence of NPPA/NPPB Haplotype on Natriuretic Peptide Plasma Levels nanCOMPLETED
Idiopathic Dilated Cardiomyopathy nanCOMPLETED
The Diurnal Rhythm in Natriuretic Peptide Levels nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NPR3 binder may also engage these)

ProteinNameSimilarity
P10730 1.000 P10730 →
P41740 1.000 P41740 →
P70180 0.997 P70180 →
Q86GV3 0.990 Q86GV3 →
O02740 0.989 O02740 →
Q80T41 0.989 Q80T41 →
Q9GYQ4 0.988 Q9GYQ4 →
A8WPG9 0.986 A8WPG9 →
O16544 0.986 O16544 →
Q5SDA5 0.986 Q5SDA5 →
Q23681 0.985 Q23681 →
P11528 0.985 P11528 →
N1NVB7 0.985 N1NVB7 →
Q09435 0.984 Q09435 →
Q7JQ32 0.984 Q7JQ32 →
P55205 0.983 P55205 →
Q23310 0.983 Q23310 →
Q7XP59 0.983 Q7XP59 →
Q6TL19 0.983 Q6TL19 →
P51842 0.983 P51842 →
MBTPS1 Membrane-bound transcription factor site-1 protease 0.983 landscape →
Q23682 0.982 Q23682 →
Q75ZY9 0.981 Q75ZY9 →
P55203 0.981 P55203 →
G5ECB2 0.981 G5ECB2 →
P23897 0.981 P23897 →
Q2QLA9 0.981 Q2QLA9 →
Q07DZ1 0.981 Q07DZ1 →
Q27675 0.981 Q27675 →
P91550 0.981 P91550 →